Pharmacy News

The Purdue University College of Pharmacy has received a $20 million commitment from alumnus Marcel Sassola III to establish a new leadership academy that will expand the college’s offerings and prepare a new pipeline of pharmacy graduates to innovate and lead in an ever-changing health care landscape.

What do spaceships, strawberries and vaccines have in common? More than you might think. The short answer is that Purdue University engineer Alina Alexeenko is tinkering with ways to make processes involved in each safer, faster and more effective.

Purdue University and Eli Lilly and Company (NYSE: LLY) are establishing an innovative new pharmaceutical manufacturing scholarship program and have renewed their strategic research collaboration in a series of moves that will expand their impact in Indiana and improve lives on a global scale. Lilly has committed $92.5 million to the West Lafayette campus through these two programs.

Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.

A strategic hiring effort to expand Purdue University’s focus in public health and health equity while diversifying the racial makeup of its faculty has reached a major milestone, with 11 new faculty starting their Boilermaker academic careers this fall.

A generous donation from a pioneer in pharmaceutical and biotechnology manufacturing will establish the William D. Young Institute for Advanced Manufacturing of Pharmaceuticals at Purdue University. The university institute, approved by the Purdue University Board of Trustees on Friday (June 10) and launched with a gift from William D. Young, will unite faculty in overhauling pharmaceutical manufacturing with a goal of reducing costs and expanding access to innovative drugs emerging from biotechnology research.

The Purdue College of Pharmacy’s most generous donors have made history by funding the first-ever termed deanship at the university.

Purdue University researchers in the College of Pharmacy and College of Engineering are developing a patent-pending treatment that could impact millions of American lives each year.

The 2019 National Survey on Drug Use and Health reported that 14.5 million people ages 12 and older have alcohol use disorder, or AUD. This represents 5.3% of that population, according to the National Institute on Alcohol Abuse and Alcoholism.

Purdue University is launching one of the largest faculty hiring initiatives in its history as a key part of a $75 million Equity Task Force effort to diversify the racial makeup of its faculty ranks. Over the next five years, 40 full-time faculty will be added through several academic clusters as part of this initiative.

Dr. Jerome Adams, former Indiana state health commissioner and the 20th U.S. surgeon general, will join Purdue University on Friday (Oct. 1) as a Presidential Fellow and the university’s first executive director of health equity initiatives, professor of practice in the departments of Pharmacy Practice and Public Health and a faculty member of the Regenstrief Center for Healthcare Engineering at Purdue.

Pharmacologists are working to help mitigate the detrimental side effects of opiates, including addiction, respiratory depression, constipation and alcohol use. Many pharmacologists are doing this by developing drugs that target the G-protein pathway, rather than the β-arrestin pathway, which historically has been associated only with adverse effects of opioids.

A possible target for a drug therapy for Parkinson's disease has been identified by a research team led by scientists at Purdue University.

Many types of human cancers exhibit changes in kinase and phosphatase balances. Drugs that inhibit kinase activity have shown success in the clinic as cancer therapeutics, but the phosphatases still remain a largely underexploited target class due primarily to the lack of understanding of how they cause diseases.

A Purdue University-affiliated life science diagnostic startup is seeing growing interest and support for its innovations focused on detecting and pre-empting the risks of debilitating diseases such as certain cancers.

Purdue University is offering an online course to prepare students to apply to Purdue’s professional pharmacy program and pique their interest in the pharmacy profession.

Purdue University’s volunteer group of faculty and staff is asking for help to provide isolation gowns for first responders and health care workers dealing with the COVID-19 virus.

Bindley Bioscience Center in Purdue University’s Discovery Park has signed an agreement with Eyestem Research Private Limited, Bangalore, India, to develop cellular platforms for COVID-19 research.

A volunteer team of faculty and staff members at Purdue University have spent the past two weeks manufacturing, assembling and delivering medical supplies to hospitals, emergency management organizations, nursing homes, and hospice care organizations.

You will want to read these good stories that you may have missed.